Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1979-01-22
1979-11-27
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
546 18, 546174, 546 89, C07D49120, A61K 3147, C07D51320
Patent
active
041761855
ABSTRACT:
Novel spiro-quinolylhydantoin derivatives useful as aldose reductase inhibitors and as therapeutic agents for the treatment of chronic diabetic complications are disclosed. Preferred compounds include spiro[imidazolidin-4,4'-pyrano[3,2-h]quinolin]-2,5-dione and spiro[imidazolidin-4,4'-pyrano[2,3-f]quinolin]-2,5-dione.
REFERENCES:
patent: 3876659 (1975-04-01), Houlihan et al.
patent: 4117230 (1978-09-01), Sarges
Bond Robert T.
Knuth Charles J.
Murphy Francis X.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Spiro-quinolylhydantoins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spiro-quinolylhydantoins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiro-quinolylhydantoins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-803123